Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:01 am
Author: Getaka|Social: XLinkedIn

Healthcare Global Enterprises Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹760.83Undervalued by 42.21%vs CMP ₹535.00

P/E (294.0) × ROE (5.1%) × BV (₹61.70) × DY (2.00%)

₹273.07Overvalued by 48.96%vs CMP ₹535.00
MoS: -95.9% (Negative)Confidence: 53/100 (Moderate)Models: 1 Under, 5 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹616.3333%Under (+15.2%)
Graham NumberEarnings₹43.2924%Over (-91.9%)
Net Asset ValueAssets₹61.6711%Over (-88.5%)
EV/EBITDAEnterprise₹280.0213%Over (-47.7%)
Earnings YieldEarnings₹13.5011%Over (-97.5%)
Revenue MultipleRevenue₹148.518%Over (-72.2%)
Consensus (6 models)₹273.07100%Overvalued
Key Drivers: EPS CAGR -19.0% drags value — could be higher if earnings stabilize. | P/E of 294 makes PE-ROE unreliable — asset/earnings models are better benchmarks.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -19.0%

*Investments are subject to market risks

Investment Snapshot

48
Healthcare Global Enterprises Ltd scores 48/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health42/100 · Moderate
ROCE 8.6% AverageROE 5.1% WeakD/E 0.59 ModerateInterest Coverage 0.0x RiskyProfitable 4/5 years Consistent
Smart Money75/100 · Strong
FII holding up 0.78% (6mo) Slight increaseDII holding up 5.82% MF buyingPromoter holding at 63.8% Stable
Earnings Quality60/100 · Moderate
OPM stable around 17% SteadyWorking capital: -91 days (improving) Efficient
Quarterly Momentum50/100 · Moderate
Revenue (4Q): +18% YoY GrowingProfit (4Q): -31% YoY Declining
Industry Rank20/100 · Weak
P/E 294.0 vs industry 75.2 Premium to peersROCE 8.6% vs industry 14.7% Below peersROE 5.1% vs industry 13.9% Below peers3Y sales CAGR: 17% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:01 am

Market Cap 7,990 Cr.
Current Price 535
Intrinsic Value₹273.07
High / Low 800/498
Stock P/E294
Book Value 61.7
Dividend Yield0.00 %
ROCE8.56 %
ROE5.14 %
Face Value 10.0
PEG Ratio-15.48

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Healthcare Global Enterprises Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Healthcare Global Enterprises Ltd 7,990 Cr. 535 800/498294 61.70.00 %8.56 %5.14 % 10.0
Metropolis Healthcare Ltd 8,796 Cr. 424 566/32950.3 69.10.24 %14.7 %11.5 % 2.00
Thyrocare Technologies Ltd 5,762 Cr. 362 538/22043.8 32.41.93 %26.5 %17.4 % 10.0
Indraprastha Medical Corporation Ltd 3,664 Cr. 400 641/32220.0 71.81.13 %39.1 %30.0 % 10.0
Artemis Medicare Services Ltd 3,528 Cr. 223 306/20335.5 56.00.20 %14.9 %12.9 % 1.00
Industry Average26,819.31 Cr611.5975.1783.710.36%14.71%13.91%9.04

All Competitor Stocks of Healthcare Global Enterprises Ltd

Quarterly Result

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 420425442461487470495526554559585613647
Expenses 345349365386402391403435451470480505524
Operating Profit 757676748579929110288106108123
OPM % 18%18%17%16%17%17%19%17%18%16%18%18%19%
Other Income 245336991161083
Interest 26272626272927343641444544
Depreciation 41414241434446475057585863
Profit before tax 101113111811281928-3141220
Tax % 47%63%57%65%40%69%17%28%25%-335%50%50%-4%
Net Profit 546411323142187621
EPS in Rs 0.530.540.600.550.970.411.530.871.290.500.530.341.15

Last Updated: January 1, 2026, 12:16 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 24, 2026, 8:46 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 4515195847008299761,0921,0091,3951,6911,9082,2182,478
Expenses 4134434995957138649368871,1611,3941,5811,8352,032
Operating Profit 387685105116112157122234297327384446
OPM % 9%15%15%15%14%11%14%12%17%18%17%17%18%
Other Income 30-210251010-7211015243910
Interest 32343823427013811998104109155178
Depreciation 363944577185148159158163174211239
Profit before tax -27303527-33-119-2298845685739
Tax % 20%-56%-730%34%38%-7%5%-3%56%61%39%14%
Net Profit -32522317-31-125-2213918414926
EPS in Rs -5.210.12-0.172.592.36-2.82-12.03-15.433.872.113.463.191.35
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)115.62%-60.00%1050.00%-26.09%-282.35%-303.23%-76.80%117.65%-53.85%127.78%19.51%
Change in YoY Net Profit Growth (%)0.00%-175.62%1110.00%-1076.09%-256.27%-20.87%226.43%194.45%-171.49%181.62%-108.27%

Healthcare Global Enterprises Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:16%
5 Years:15%
3 Years:17%
TTM:17%
Compounded Profit Growth
10 Years:52%
5 Years:19%
3 Years:73%
TTM:-26%
Stock Price CAGR
10 Years:%
5 Years:42%
3 Years:37%
1 Year:70%
Return on Equity
10 Years:-1%
5 Years:0%
3 Years:5%
Last Year:5%

Last Updated: September 5, 2025, 5:55 am

Balance Sheet

Last Updated: December 4, 2025, 1:21 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 68708586878889125139139139139141
Reserves 196210341347428389293572731721686783780
Borrowings 2923493244204646581,3479779159011,2741,8371,768
Other Liabilities 133147294372461515518357433549601780897
Total Liabilities 6887761,0431,2251,4401,6502,2462,0312,2182,3112,7013,5403,586
Fixed Assets 5125285836858289701,6461,3821,5471,5531,7582,4422,430
CWIP 114212114817415346302218832596
Investments 20641153493426910101113
Other Assets 1642052753813854785205936417308501,0621,048
Total Assets 6887761,0431,2251,4401,6502,2462,0312,2182,3112,7013,5403,586

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 516073919898130121220252285317
Cash from Investing Activity + -12-79-204-210-283-238-101-171125-133-226-488
Cash from Financing Activity + -27222168916184-58112-155-140-64-42
Net Cash Flow 13285-29-24-56-3062190-22-5-213
Free Cash Flow 52-20-137-101-158-902385150126101110
CFO/OP 156%87%99%93%88%121%100%68%104%92%101%91%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-254.00-273.00-239.00-315.00-348.00-546.00156.00-855.00-681.00-604.00326.00383.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 434543545759626757655666
Inventory Days 333632404645353231333333
Days Payable 193208264272274303234221199214216210
Cash Conversion Cycle -117-127-188-178-171-200-136-121-112-116-127-111
Working Capital Days -20-65-96-112-74-110-102-26-43-40-70-91
ROCE %1%7%6%7%6%3%1%-1%5%8%9%9%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 71.37%71.35%71.30%71.29%71.28%71.26%71.23%71.22%71.22%62.46%63.78%63.77%
FIIs 6.37%6.47%6.29%6.37%6.74%3.95%4.30%2.77%2.44%2.16%3.59%3.22%
DIIs 5.53%6.58%7.94%8.46%8.52%10.89%11.64%12.94%12.48%13.22%18.36%18.30%
Public 16.71%15.59%14.49%13.89%13.45%13.90%12.84%13.07%13.86%22.17%14.28%14.71%
No. of Shareholders 28,85825,93127,32727,28927,19526,52929,67032,82045,39447,02846,97045,366

Shareholding Pattern Chart

No. of Shareholders

Healthcare Global Enterprises Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Nippon India Small Cap Fund 4,400,000 0.4 260.5N/AN/AN/A
Motilal Oswal Multi Cap Fund 3,500,000 5.04 207.22N/AN/AN/A
Nippon India ELSS Tax Saver Fund 3,500,000 1.39 207.22N/AN/AN/A
Axis Small Cap Fund 2,120,271 0.49 125.531,690,2712026-02-23 02:27:3825.44%
Motilal Oswal Business Cycle Fund 1,750,000 5.54 103.61N/AN/AN/A
Axis Flexi Cap Fund 1,108,115 0.52 65.611,017,3662026-02-23 00:29:358.92%
Tata India Pharma & HealthCare Fund 1,075,346 5.14 63.67958,5752026-02-23 02:27:3812.18%
Tata Focused Fund 883,709 2.91 52.32828,7092026-02-23 02:27:386.64%
Tata ELSS Fund 632,894 0.82 37.47N/AN/AN/A
Bandhan Midcap Fund 201,141 0.63 11.91203,1412026-01-26 07:56:25-0.98%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 3.193.462.114.14-17.02
Diluted EPS (Rs.) 3.143.432.103.97-17.02
Cash EPS (Rs.) 18.6115.4613.0214.29-4.91
Book Value[Excl.RevalReserv]/Share (Rs.) 66.1659.2861.8663.5756.96
Book Value[Incl.RevalReserv]/Share (Rs.) 66.1659.2861.8663.5756.96
Revenue From Operations / Share (Rs.) 159.44136.97121.58100.5580.84
PBDIT / Share (Rs.) 30.2824.8822.4218.0311.45
PBIT / Share (Rs.) 15.1212.3610.676.64-1.25
PBT / Share (Rs.) 4.034.833.236.42-18.21
Net Profit / Share (Rs.) 3.452.941.272.90-17.61
NP After MI And SOA / Share (Rs.) 3.193.462.113.87-15.43
PBDIT Margin (%) 18.9818.1618.4317.9314.16
PBIT Margin (%) 9.489.028.776.60-1.54
PBT Margin (%) 2.523.522.656.38-22.52
Net Profit Margin (%) 2.162.141.042.88-21.78
NP After MI And SOA Margin (%) 1.992.521.733.84-19.08
Return on Networth / Equity (%) 4.815.833.416.17-27.74
Return on Capital Employeed (%) 8.448.768.505.27-0.99
Return On Assets (%) 1.251.771.262.42-9.50
Long Term Debt / Equity (X) 0.650.580.420.410.49
Total Debt / Equity (X) 1.090.810.460.460.59
Asset Turnover Ratio (%) 0.710.750.740.460.31
Current Ratio (X) 0.800.911.021.070.93
Quick Ratio (X) 0.750.850.951.010.88
Inventory Turnover Ratio (X) 46.460.000.000.000.00
Interest Coverage Ratio (X) 2.733.193.012.561.20
Interest Coverage Ratio (Post Tax) (X) 1.311.341.170.44-0.06
Enterprise Value (Cr.) 8223.425119.813866.173975.482784.14
EV / Net Operating Revenue (X) 3.702.682.292.842.75
EV / EBITDA (X) 19.4814.7712.4015.8619.40
MarketCap / Net Operating Revenue (X) 3.372.472.162.682.36
Price / BV (X) 8.135.704.254.313.44
Price / Net Operating Revenue (X) 3.372.472.162.682.36
EarningsYield 0.010.010.010.01-0.08

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Healthcare Global Enterprises Ltd. is a Public Limited Listed company incorporated on 12/03/1998 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L15200KA1998PLC023489 and registration number is 023489. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 1280.49 Cr. and Equity Capital is Rs. 139.42 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesHCG Tower, Bengaluru Karnataka 560027Contact not found
Management
NamePosition Held
Dr. B S Ajai KumarExecutive Chairman
Dr. Manish MattooExecutive Director & CEO
Ms. Anjali AjaikumarNon Exe.Non Ind.Director
Mr. Akshay TannaNon Exe.Non Ind.Director
Ms. Simrun MehtaNon Exe.Non Ind.Director
Ms. Geeta MathurInd. Non-Executive Director
Mr. Pradip KanakiaInd. Non-Executive Director
Mr. Rajiv MaliwalInd. Non-Executive Director
Mr. Raj RaghavanInd. Non-Executive Director
Mr. Bijou KurienInd. Non-Executive Director

FAQ

What is the intrinsic value of Healthcare Global Enterprises Ltd and is it undervalued?

As of 14 April 2026, Healthcare Global Enterprises Ltd's intrinsic value is ₹273.07, which is 48.96% lower than the current market price of ₹535.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (5.14 %), book value (₹61.7), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd is trading at ₹535.00 as of 14 April 2026, with a FY2026-2027 high of ₹800 and low of ₹498. The stock is currently near its 52-week low. Market cap stands at ₹7,990 Cr..

How does Healthcare Global Enterprises Ltd's P/E ratio compare to its industry?

Healthcare Global Enterprises Ltd has a P/E ratio of 294, which is above the industry average of 75.17. This significantly elevated P/E suggests the market expects strong future growth, or the stock may be overpriced relative to current earnings.

Is Healthcare Global Enterprises Ltd financially healthy?

Key indicators for Healthcare Global Enterprises Ltd: ROCE of 8.56 % is on the lower side compared to the industry average of 14.71%; ROE of 5.14 % is below ideal levels (industry average: 13.91%). Dividend yield is 0.00 %.

Is Healthcare Global Enterprises Ltd profitable and how is the profit trend?

Healthcare Global Enterprises Ltd reported a net profit of ₹49 Cr in Mar 2025 on revenue of ₹2,218 Cr. Compared to ₹39 Cr in Mar 2022, the net profit shows an improving trend.

Does Healthcare Global Enterprises Ltd pay dividends?

Healthcare Global Enterprises Ltd has a dividend yield of 0.00 % at the current price of ₹535.00. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Healthcare Global Enterprises Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports